Progesterone Receptor Expression Level Within Immunohistochemically Determined Early Stage Node Negative Luminal-B Breast Cancer: Forecasting Implication, Outcome and Concordance to Oncotype-DX Recurrence Scores
like breast cancers with Ki67 between ≥ 14% and <30% alongside their potentials in forecasting the outcome. Methods: The impact of PR variations on Oncotype-Dx RS alongside their implications ... both Luminal-B1and B2…

